Skip to main content
. 2020 Mar 13;9(10):3337–3343. doi: 10.1002/cam4.2986

FIGURE 4.

FIGURE 4

Combination therapy with irinotecan and 5‐fluorouracil in the patient‐derived xenograft. The tumor growth inhibition rate following treatment with irinotecan +5‐fluorouracil is 0.46. Eight tumors from six mice in the control group and eight tumors from five mice in the combination group were assessed. The combination treatment shows statistically significant growth inhibition compared to the control group (P = .00002). P* indicated P < .05